1. Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part II. Hematological Markers of Inflammation
   Natalia S. Sergeeva et al, 2023, Annals of the Russian academy of medical sciences CrossRef
2. Hematological ratios as prognostic indicators in patients with triple-negative breast cancer in southern Brazil
   Camila Macedo Boaro et al, 2022, Mastology CrossRef
3. Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
   Yinuo Li et al, 2023, Scientific Reports CrossRef
4. Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer
   Svetlana Miklikova et al, 2020, Cancers CrossRef
5. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
   Sejdi Lusho et al, 2021, Frontiers in Oncology CrossRef
6. Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
   Marta Truffi et al, 2022, Cancers CrossRef
7. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
   Céline Blaye et al, 2022, Frontiers in Immunology CrossRef
8. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis
   Angelo Zinellu et al, 2021, Journal of Clinical Medicine CrossRef
9. Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection
   Wen Li et al, 2021, Frontiers in Oncology CrossRef
10. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
    Qian-Qian Liao et al, 2024, International Journal of Chronic Obstructive Pulmonary Disease CrossRef
11. Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
    Camille Domergue et al, 2022, Cancers CrossRef
12. A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Cong Jiang et al, 2022, Disease Markers CrossRef
13. A real‐world study of immune checkpoint inhibitors in advanced triple‐negative breast cancer
    Zheng Zhang et al, 2023, Cancer Innovation CrossRef
14. Association of a High Neutrophil-to-Lymphocyte Ratio with Hyperdense Artery Sign and Unfavorable Short-Term Outcomes in Patients with Acute Ischemic Stroke
    Shinn-Kuang Lin et al, 2021, Journal of Inflammation Research CrossRef
15. In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells
    Sabine Kasimir-Bauer et al, 2022, Cancers CrossRef